The objective of the Pandemic Influenza Preparedness Framework is to improve pandemic influenza preparedness and response, and strengthen the protection against the pandemic influenza by improving and strengthening the WHO global influenza surveillance and response system (“WHO GISRS”), with the objective of a fair, transparent, equitable, efficient, effective system for, on an equal footing:
(i) the sharing of H5N1 and other influenza viruses with human pandemic potential; and
(ii) access to vaccines and sharing of other benefits.
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical specimens shared under this Framework
This second edition of the Pandemic Influenza Preparedness (PIP) Framework reflects an amendment to Annex 2, Standard Material Transfer Agreement 2, Footnote 1, that was adopted by the Seventy-second World Health Assembly in May 2019.The amendment clarifies that, under certain circumstances, the indirect use of PIP Biological Materials will require the conclusion of an SMTA2. The amendment is in effect from the closure of the Seventy-second World Health Assembly (28 May 2019).
Entire content available on: https://www.who.int/publications/i/item/9789240024854
Language
EnglishTypology
Guidelines/Recommendations/Technical Instructions Overviews/FrameworksTopic
Vaccine Influenza Outbreak PreparednessTarget
Public HealthCountries
USA Canada South America Central America Caribbean Middle East South pacific China India Indochina Singapore Europe & UK Oceania Africa